Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE

Completed · Not applicable

Conditions studied: Atherosclerotic Disease, Carotid

In brief

This purpose of this study is to collect data on the FDA-approved ACCULINK(TM) Carotid Stent System and FDA 510(k)-cleared ACCUNET(TM) Embolic Protection System for the treatment of patients with atherosclerotic disease, when used by physicians under commercial use conditions.

Key facts

Study ID

NCT00180492

Run by

Abbott Medical Devices

People needed

1500

Starts

2004-10-01

Expected to finish

2007-08-01

Last updated by the study team

2008-10-29

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient's physician used an ACCULINK and/or ACCUNET

Where it is running

• Guidant Corporation — Santa Clara, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.